The latest T1D content
Research that matters
Our daily questions
Continue with Google
Continue with Facebook
Articles
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
All About The T1D Exchange Quality Improvement Collaborative (QIC)
Providing supportive care for those living with T1D is complex and comes with an ongoing responsibility of knowing how to…
T1D at the Big Game!
Type 1 diabetes will be grabbing the spotlight this weekend! Nick Jonas will be in a commercial for Dexcom airing…
Screening for T1D: Using the New T1Detect Kit
Top Questions of the Day – January 2021
What We Learned from the Online Community in January We learn something new every day from this community’s Question of…
Chatting with Dexcom CEO About the New G7, the Sampling Program, and the Patient Voice
There are approximately 900,000 people across the globe wearing a Dexcom continuous glucose monitor (CGM) today. “Up from 600,000 at…
We Honor These Words
“Life’s most urgent and persistent question is, What are you doing for others?” – Martin Luther King Jr T1D Exchange…
Glucose Revival Founder Kris Maynard Makes T1D Life Easier
Have you ever been going about your daily routine (either exercising, traveling, or just spending an evening with friends or…
Tidepool Completes FDA 510(k) Submission of Tidepool Loop
Open Source Diabetes Nonprofit Submits Automated Insulin Dosing App for iPhone for FDA Review Tidepool, a 501(c)3 nonprofit, today announced…
Racial Inequities Among People with Type 1 Diabetes and COVID-19
T1D Exchange is honored to have our recent study results examining racial inequities among people with type 1 diabetes and COVID-19 included in two major publications. Structural and systemic…
Drum Roll, Please: The Most Interesting Facts of 2020
This National Diabetes Awareness Month, we shared 30 Facts in 30 Days about the T1D Exchange Registry: our comprehensive research study of people with type 1 diabetes…
And the Winner Is: The Top Questions of 2020
At T1D Exchange, we learn so much from the vast T1D experience of our online community. Today we’re sharing the three…
Question of the day
If you wear a CGM, have you ever extended your sensor past its approved session duration?
T1D Exchange@T1D Exchange
T1D Exchange@T1D ExchangeT1D Exchange@T1D Exchange
